-

Shareholder Alert: Robbins LLP Investigates Acquisition of Avalara, Inc. (AVLR) by Vista Equity Partners for $8.4 Billion

SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP informs investors it is investigating the acquisition of Avalara, Inc. (NYSE: AVLR) by Vista Equity Partners. Under the terms of the agreement, Avalara stockholders will receive $93.50 in cash for each share of Avalara common stock owned.

If you own shares of Avalara, Inc., click here.

Is the Proposed Acquisition Best for Avalara, Inc. (AVLR) and Its Shareholders?

According to the Proxy Statement, Avalara's board approved a merger agreement with Vista Equity Partners in which Avalara will become a private company. The deal is valued at approximately $8.4 billion and is expected to close in the second half of 2022. Robbins LLP is concerned that Avalara's board of directors engaged in an unfair process and agreed to an unfair amount to be paid to shareholders.

Next Steps: If you own shares of Avalara, Inc. (AVLR) you have legal options. Contact us to learn more about your legal rights.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

Contact us to learn more:
Aaron Dumas
(800) 350-6003
adumas@robbinsllp.com
Shareholder Information Form

About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. To be notified if a class action against Avalara, Inc. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Aaron Dumas
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Robbins LLP

NYSE:AVLR

Release Summary
Robbins LLP Investigates Acquisition of Avalara, Inc. (AVLR) by Vista Equity Partners for $8.4 Billion
Release Versions
$Cashtags

Contacts

Aaron Dumas
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Social Media Profiles
More News From Robbins LLP

Robbins LLP Urges DNB Stockholders Who Lost Money Investing in Dun & Bradstreet Holdings, Inc. to Contact the Firm for Information About Leading the Class Action

SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP reminds investors that a class action was filed on behalf of sellers of Dun & Bradstreet Holdings, Inc. (NYSE: DNB) common stock between May 13, 2025 and August 26, 2025, inclusive (the “Class Period”), including holders who exchanged shares of Dun & Bradstreet common stock in the Merger with Clearlake Capital Group, L.P., and holders of Dun & Bradstreet common stock as of the May 9, 2025 record date for the special...

Portillo's Inc. Securities Violation Investigation - Robbins LLP is Investigating the Officers and Directors of PTLO for Breaches of Fiduciary Duty and Violations of Securities Laws

SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP is investigating Portillo’s Inc. (NASDAQ: PTLO) to determine whether certain Portillo's Inc. officers and directors violated securities laws and breached fiduciary duties to shareholders. Portillo's Inc. owns and operates fast casual restaurants in the United States. Why Are We Investigating Portillo's? On August 5, 2025, Portillo's reported second quarter 2025 financial results. Although the Company maintained its target of 12...

Robbins LLP Urges DOCS Stockholders Who Lost Money Investing in Doximity, Inc. to Contact the Firm for Information About Leading the Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP reminds investors that a class action was filed on behalf of persons and entities who purchased or otherwise acquired Doximity, Inc. (NYSE: DOCS) common stock between August 8, 2024 and May 13, 2026, inclusive (the "Class Period"). Doximity is a digital platform for medical professionals that combines health care news, workflow products, and clinician networking. The complaint alleges that Doximity failed to disclose to investo...
Back to Newsroom